| Metric | Q2 2024 | Q1 2024 | Q2 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $240M | — | — | — | — |
| Op. Income | $29M | — | — | — | — |
| Gross Margin | 32.0% | — | — | — | — |
| Net Margin | 12.4% | — | — | — | — |
| EPS (Diluted) | $0.17 | — | — | — | — |
| Free Cash Flow | $22M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $240M |
| Cost of Revenue | $163M |
| GROSS PROFIT | $77M |
| R&D Expenses | $36M |
| Selling & Marketing | $5M |
| General & Administrative | $6M |
| SG&A Expenses | $11M |
| Other Expenses | $0 |
| Operating Expenses | $47M |
| Cost & Expenses | $210M |
| OPERATING INCOME | $29M |
| Interest Income | $3M |
| Interest Expense | $1M |
| Other Income/Expenses | $2M |
| INCOME BEFORE TAX | $32M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $30M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $30M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $30M |
| D&A | $6M |
| EBIT | $33M |
| EBITDA | $38M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $240M |
| Cost of Revenue | $163M |
| GROSS PROFIT | $77M |
| R&D Expenses | $36M |
| Selling & Marketing | $5M |
| General & Administrative | $6M |
| SG&A Expenses | $11M |
| Other Expenses | $0 |
| Operating Expenses | $47M |
| Cost & Expenses | $210M |
| OPERATING INCOME | $29M |
| Interest Income | $3M |
| Interest Expense | $1M |
| Other Income/Expenses | $2M |
| INCOME BEFORE TAX | $32M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $30M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $30M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $30M |
| D&A | $6M |
| EBIT | $33M |
| EBITDA | $38M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $30M |
| Depreciation & Amortization | $6M |
| Stock-Based Compensation | $379.0K |
| Deferred Income Tax | $2M |
| Other Non-Cash Items | -$3M |
| Change in Working Capital | -$8M |
| OPERATING CASH FLOW | $27M |
| Capital Expenditure | -$5M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$56M |
| Sales/Maturities of Investments | $34M |
| Other Investing Activities | -$12.0K |
| NET CASH FROM INVESTING | -$27M |
| Net Debt Issuance | -$3M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$22M |
| NET CASH FROM FINANCING | -$25M |
| FREE CASH FLOW | $22M |
| Net Change in Cash | -$25M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $237M |
| Short-Term Investments | $17M |
| Net Receivables | $243M |
| Inventory | $204M |
| Other Current Assets | $507M |
| TOTAL CURRENT ASSETS | $1.2B |
| PP&E (Net) | $126M |
| Goodwill | $28M |
| Intangible Assets | $791.0K |
| Long-Term Investments | $57M |
| Tax Assets | $13M |
| Other Non-Current Assets | $241M |
| TOTAL NON-CURRENT ASSETS | $467M |
| TOTAL ASSETS | $1.7B |
| Account Payables | $149M |
| Short-Term Debt | $459M |
| Deferred Revenue | $34M |
| Other Current Liabilities | $113M |
| TOTAL CURRENT LIABILITIES | $763M |
| Long-Term Debt | $32M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $493.0K |
| Other Non-Current Liabilities | $15M |
| TOTAL NON-CURRENT LIABILITIES | $47M |
| TOTAL LIABILITIES | $811M |
| Common Stock | $107M |
| Additional Paid-In Capital | $115M |
| Retained Earnings | $632M |
| Treasury Stock | -$5M |
| Accum. Other Comp. Income | $9M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $857M |
| Minority Interest | $7M |
| TOTAL EQUITY | $864M |
| TOTAL LIABILITIES & EQUITY | $1.7B |
| Total Debt | $491M |
| Net Debt | $254M |
